These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7956674)

  • 21. [Role of oral hypoglycemic agents in the therapeutic approach to diabetic obesity].
    Albert J; Ekoé JM
    Sem Hop; 1983 Sep; 59(29-30):2135-40. PubMed ID: 6312587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Oral antidiabetic agents].
    Vonesch HJ
    Schweiz Rundsch Med Prax; 1988 Mar; 77(9):210-2. PubMed ID: 3283906
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical efficacy of glimepiride].
    Kaneko T; Sakamoto N
    Nihon Rinsho; 1997 Nov; 55 Suppl():152-7. PubMed ID: 9434460
    [No Abstract]   [Full Text] [Related]  

  • 24. New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus.
    DeFronzo RA; Ferrannini E; Koivisto V
    Am J Med; 1983 Jan; 74(1A):52-81. PubMed ID: 6337486
    [No Abstract]   [Full Text] [Related]  

  • 25. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E; Schnell O
    Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract]   [Full Text] [Related]  

  • 26. ATP-sensitive K+ channels and insulin secretion: their role in health and disease.
    Ashcroft FM; Gribble FM
    Diabetologia; 1999 Aug; 42(8):903-19. PubMed ID: 10491749
    [No Abstract]   [Full Text] [Related]  

  • 27. [An analysis of the causes of low-efficacy treatment in type-2 diabetes mellitus using sulfonylurea derivatives].
    Gendeleka GF
    Lik Sprava; 1996; (3-4):100-3. PubMed ID: 9035838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB
    Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
    [No Abstract]   [Full Text] [Related]  

  • 29. Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?
    Marble A
    Drugs; 1971; 1(2):109-15. PubMed ID: 4999930
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL; Wolf SL; Kabadi UM
    Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [40 years of using sulfonylurea derivatives for treatment of diabetes].
    Sieradzki J
    Przegl Lek; 1996; 53(9):641-6. PubMed ID: 8992529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Primary and secondary failure of sulphonylureas].
    Kanno H; Sakura H
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():719-23. PubMed ID: 12430308
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral hypoglycemic agents.
    Boyden T; Bressler R
    Adv Intern Med; 1979; 24():53-70. PubMed ID: 371368
    [No Abstract]   [Full Text] [Related]  

  • 34. [Approaches in diabetes therapy. 2. Selection and use of oral antidiabetics. 1) Drugs enhancing insulin secretion].
    Yoshimoto K; Ishida H
    Nihon Naika Gakkai Zasshi; 2000 Aug; 89(8):1523-9. PubMed ID: 11062899
    [No Abstract]   [Full Text] [Related]  

  • 35. The use of oral hypoglycaemic agents in the treatment of diabetes mellitus.
    Larkins RG
    Med J Aust; 1987 May; 146(9):477-80. PubMed ID: 3302638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Possibilities and limits of oral diabetes therapy].
    Bruneder H
    Wien Med Wochenschr; 1985 Apr; 135(6-7):147-51. PubMed ID: 3890376
    [No Abstract]   [Full Text] [Related]  

  • 37. [Sulfonylurea and alpha-glucosidase inhibitor].
    Iijima T
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():459-63. PubMed ID: 12387034
    [No Abstract]   [Full Text] [Related]  

  • 38. [Failure of oral hypoglycemic agents: clinical experiences in 20 years' follow-up].
    Aylwin CG; López G; García de los Riós M; Vial T; Pinto JL; Ojeda A; Orellana JL
    Rev Med Chil; 1988 Aug; 116(8):729-35. PubMed ID: 3255124
    [No Abstract]   [Full Text] [Related]  

  • 39. Seeking sweet relief for diabetes.
    Dove A
    Nat Biotechnol; 2002 Oct; 20(10):977-81. PubMed ID: 12355109
    [No Abstract]   [Full Text] [Related]  

  • 40. [Different clinical patterns of secondary drug failure in diabetes mellitus type II patients and their significance for diagnosis of secondary sulfonamide resistance].
    Gendeleka GF
    Lik Sprava; 2001; (3):158-9. PubMed ID: 11560011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.